ORAL DISSOLVABLE STRIPS (ODS) AS NEW PEDIATRIC AND ADULT DELIVERY MODE OF THERAPY FOR LATENT TUBERCULOSIS - PROJECT SUMMARY TUBERCULOSIS (TB) REMAINS ONE OF THE MAJOR SOURCES OF MORTALITY FROM INFECTIOUS DISEASES WORLDWIDE. IN 2021 AN ESTIMATED 6.4 MILLION WERE NEWLY DIAGNOSED WITH TB GLOBALLY, APPROXIMATELY 10.6 MILLION FELL ILL FROM IT, AND 1.4 MILLION DIED FROM THE DISEASE. OF THOSE WHO DIED FROM THE DISEASE, 54% WERE MEN, 32% WOMEN, AND 14% WERE CHILDREN AGED